Advertisement

Pharmacy World & Science

, Volume 32, Issue 5, pp 552–558 | Cite as

Clinical value of blood pressure measurement in the community pharmacy

  • Daniel Sabater-HernándezEmail author
  • Inés Azpilicueta
  • Pablo Sánchez-Villegas
  • Pedro Amariles
  • María I. Baena
  • María J. Faus
Review Article

Abstract

Aim of the study To investigate whether the measurement of blood pressure in the community pharmacy is a valuable method to diagnose hypertension, to assess the need and the effectiveness of anti-hypertensive treatments, or, in general, to make clinical decisions. Method Information has been extracted from articles published in English and in Spanish, from January 1989 to December 2009, in indexed magazines in MEDLINE and EMBASE. To perform the search, multiple and specified terms related to the community pharmacy setting, to blood pressure measurement and to the comparison and agreement between blood pressure measurement methods were used. Selected articles were those that: (1) compared and/or measured the agreement (concordance) between community pharmacy blood pressure measurements obtained in repeated occasions, or (2) compared and/or measured the agreement between the community pharmacy blood pressure measurement method and other measurement methods used in clinical practice for decision-making purposes: blood pressure measurement by a physician, by a nurse and home or ambulatory blood pressure monitoring. Articles were included and analyzed by two investigators independently, who essentially extracted the main results of the manuscripts, emphasizing the assessment of the blood pressure measurement methods used and the completed statistical analysis. Results Only three studies comparing the community pharmacy blood pressure measurement method with other methods and one comparing repeated measurements of community pharmacy blood pressure were found. Moreover, these works present significant biases and limitations, both in terms of method and statistical analysis, which make difficult to draw consistent conclusions. Conclusion Further research of high quality is needed, which results can guide the clinical decision-making based on the community pharmacy blood pressure measurement method.

Keywords

Blood pressure Blood pressure measurement Community pharmacy services Concordance Hypertension Pharmaceutical services 

Notes

Acknowledgments

To LACER laboratories, for their collaboration in the translation of this paper and to Eleonora Feletto for assistance in editing the text.

Funding

None.

Conflicts of interest

There are no conflicts of interest to declare by the authors.

References

  1. 1.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMedGoogle Scholar
  2. 2.
    Burke JM, Miller WA, Spencer AP, Crank CW, Adkins L, Bertch KE, et al. Clinical pharmacist competencies. Pharmacotherapy. 2008;28:806–15.CrossRefPubMedGoogle Scholar
  3. 3.
    Parati G, Bilo G, Mancia G. Blood pressure measurement in research and in clinical practice: recent evidence. Curr Opin Nephrol Hypertens. 2004;13:343–57.CrossRefPubMedGoogle Scholar
  4. 4.
    Carrasco JL, Jover L. Statistical approaches to evaluate agreement. Med Clin (Barc). 2004;122(Suppl 1):28–34.CrossRefGoogle Scholar
  5. 5.
    Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–87.CrossRefPubMedGoogle Scholar
  6. 6.
    Divison J, Artigao L, Sanchis C, Alvarez F, Carbayo J, Carrion L, et al. Can or should blood pressure be measured at pharmacy offices? Aten Primaria. 2001;28:4–9.PubMedGoogle Scholar
  7. 7.
    Botomino A, Martina B, Ruf D, Bruppacher R, Hersberger KE. White coat effect and white coat hypertension in community pharmacy practice. Blood Press Monit. 2005;10:13–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Abellan Aleman J, Gil Guillen V, Merino Sanchez J, Llisterri Caro JL, Leal Hernandez M. The ZANyCONTROL study. The role of the pharmacy. Rev Clin Esp. 2008;208:483–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Karwalajtys T, Kaczorowski J, Hutchison B, Myers MG, Sullivan SM, Chambers LW, et al. Blood pressure variability and prevalence of hypertension using automated readings from multiple visits to a pharmacy-based community-wide programme. J Hum Hypertens. 2009;23:585–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Viera AJ, Cohen LW, Mitchell CM, Sloane PD. Hypertensive patients’ use of blood pressure monitors stationed in pharmacies and other locations: a cross-sectional mail survey. BMC Health Serv Res. 2008;8:216.CrossRefPubMedGoogle Scholar
  11. 11.
    Coca A, Bertomeu V, Dalfo A, Esmatjes E, Guillen F, Guerrero L, et al. Self-measurement of blood pressure. Consensus Paper Spain 2007. Rev Clin Esp. 2007;207:197–208.CrossRefPubMedGoogle Scholar
  12. 12.
    Tsuyuki R, Campbell N. 2007 CHEP-CPhA guidelines for the management of hypertension by pharmacists. Can Pharm J. 2007;140:238–9.CrossRefGoogle Scholar
  13. 13.
    Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:10–29.CrossRefPubMedGoogle Scholar
  14. 14.
    Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41:1770–81.CrossRefPubMedGoogle Scholar
  15. 15.
    Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008;26:1505–26.CrossRefPubMedGoogle Scholar
  16. 16.
    Pickering TG, Gerin W, Schwartz AR. What is the white-coat effect and how should it be measured? Blood Press Monit. 2002;7:293–300.CrossRefPubMedGoogle Scholar
  17. 17.
    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–10.PubMedGoogle Scholar
  18. 18.
    Parati G, Stergiou GS. Self measured and ambulatory blood pressure in assessing the ‘white-coat’ phenomenon. J Hypertens. 2003;21:677–82.CrossRefPubMedGoogle Scholar
  19. 19.
    Sabater-Hernández D, Baena MI, Sánchez-Villegas P, Amariles P, García-Corpas JP, Faus MJ, et al. Magnitude and variability of the white coat effect at multiple visits to community pharmacies. Preliminary results of the blood pressure measurement study in community pharmacies: the MEPAFAR study (abstract). Pharm World Sci. 2010;32:262.CrossRefGoogle Scholar
  20. 20.
    Sabater-Hernández D, Fikri-Benbrahim O, Faus MJ. Usefulness of ambulatory blood pressure monitoring for clinical decisions making. Med Clin (Barc). 2010;135:23–9.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Daniel Sabater-Hernández
    • 1
    Email author
  • Inés Azpilicueta
    • 1
  • Pablo Sánchez-Villegas
    • 2
  • Pedro Amariles
    • 3
  • María I. Baena
    • 1
  • María J. Faus
    • 1
  1. 1.Grupo de Investigación en Atención FarmacéuticaUniversidad de GranadaGranadaSpain
  2. 2.Andalusian School of Public HealthGranadaSpain
  3. 3.Faculty of Pharmacy, University of Antioquia (Medellin, Colombia), Pharmaceutical Care Research GroupUniversity of GranadaGranadaSpain

Personalised recommendations